Christopher Bi is the Executive Director of Integrative Sciences at Bristol Myers Squibb, a role they have held since 2022. They serve on the Board of Directors for the Structural Genomics Consortium and act as a Board Observer for Nitrase Therapeutics, both positions starting in 2021. Christopher earned a PhD from Stanford University from 1998 to 2003 and an EMBA from the Rady School of Management at UCSD from 2010 to 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices